Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ADTL-SA1215 is a novel, highly selective small-molecule compound that acts as a specific activator of SIRT3, a protein known to play a crucial role in modulating autophagy. This compound holds great potential in the treatment of triple-negative breast cancer, as it effectively targets the molecular pathways associated with this subtype of cancer.
Description | ADTL-SA1215 is a novel, highly selective small-molecule compound that acts as a specific activator of SIRT3, a protein known to play a crucial role in modulating autophagy. This compound holds great potential in the treatment of triple-negative breast cancer, as it effectively targets the molecular pathways associated with this subtype of cancer. |
Synonyms | ADTL-SA1215 |
Molecular Weight | 657.331 |
Formula | C26H29I2NO3 |
CAS No. | 782387-91-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ADTL-SA1215 782387-91-1 ADTL-SA 1215 ADTL-SA-1215 ADTLSA1215 ADTL SA1215 inhibitor inhibit